Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN102336763B details a high-yield gold-catalyzed route for pyranocoumarins. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical intermediates.
Novel palladium-catalyzed carbonylation route offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN110467555B details a chiral phosphoric acid catalyzed method for high-purity axial chiral aryl indoles, offering cost-effective routes for oncology drug development.
Patent CN115772157A details a cost-effective cobalt-catalyzed C-H activation method for 2-alkoxyindoles, offering significant supply chain advantages for pharmaceutical manufacturing.
Novel FeCl3-catalyzed route for 2-CF3 quinazolinones. High yield, scalable process for API intermediates. Cost-effective manufacturing solution.
Patent CN114160206B reveals a novel chiral copper catalyst enabling high-yield, enantioselective synthesis of indole intermediates with superior purity and scalability.
Novel Pd-catalyzed carbonylation method for 2-trifluoromethyl quinazolinones offers high yields and broad substrate scope, enabling cost-effective manufacturing of drug molecules like Rutaecarpine.
Novel Pd-catalyzed method using nitro compounds reduces cost and improves supply chain reliability for pharmaceutical intermediates manufacturing processes globally.
Novel Mo/Cu co-catalyzed method for trifluoromethyl triazoles offers mild conditions and high yields for reliable API intermediate supply chains.
Patent CN111675662B reveals a novel FeCl3-catalyzed route for 2-trifluoromethyl quinazolinones, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel Pd-catalyzed method for trifluoromethyl chromone quinoline. Enhances supply chain reliability and cost efficiency for pharmaceutical intermediates.
Novel nickel-catalyzed carbonylation method for 2-pyrrolidone derivatives offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel palladium-catalyzed carbonylation for pyrone derivatives. Cost-effective, scalable process for pharmaceutical intermediates supply chain optimization.
Patent CN112898192B details a safe carbonylation route for N-acyl indoles using solid CO sources, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN117247370A enables room-temperature thioflavonoid synthesis using CO2. Offers cost reduction and scalable supply for pharmaceutical intermediate manufacturing.
Patent CN113683595B reveals sulfur-promoted synthesis eliminating explosive peroxides. Enables cost reduction and reliable supply chain for high-purity pharmaceutical intermediates.
Novel silver oxide promoted synthesis route for high purity pharmaceutical intermediates offering significant cost reduction and supply chain reliability for global buyers.
Patent CN112538054B details a novel Pd-catalyzed carbonylation route for 1,2,4-triazol-3-ones, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN108558927B details a novel Pd-catalyzed asymmetric alkenylation for silicon stereocenters. Discover cost-effective routes for high-purity pharmaceutical intermediates.
Patent CN112480015B details a Pd-catalyzed one-pot synthesis. Offers cost reduction in API manufacturing and high-purity pharmaceutical intermediates with scalable protocols.